MORPHINE SULFATE INJECTION RECALLED

Hospira, Inc. (NYSE: HSP), announced today it is initiating a voluntary user level recall of one lot of Morphine Sulfate Injection USP, 4 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject, NDC 0409-1258-30, due to a customer report of two Carpujects syringes containing more than the 1 mL labeled fill volume. Opioid pain medications such as morphine have life-threatening consequences if overdosed.

For more information on the recall, click here

If you or someone you know, suspects they have been injured by an overdose of a morphine injection, contact the Kalispell law firm of ANDERSON & BLIVEN P.C.

Our law firm has three Kalispell lawyers who represent the innocent victims of those who have been harmed by the negligence of others.

In addition to personal injury and product liability, the three Kalispell attorney firm of ANDERSON & BLIVEN P.C. represents injured individuals with Workers Compensation and Social Security Disability claims.

 

This entry was posted in Product Liability, Recalls and tagged , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

9,307 Spam Comments Blocked so far by Spam Free Wordpress

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>